Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.

Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.

Item
http://www.wikidata.org/entity/Q33368368
Teicoplanin versus vancomycin for proven or suspected infectionEstimating the potential annual welfare impact of innovative drugs in use in Switzerland.Revisiting Methicillin-Resistant Staphylococcus aureus Infections.Linezolid for the treatment of drug-resistant infections.Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.Linezolid: effectiveness and safety for approved and off-label indications.Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections.Sequential antimicrobial treatment with linezolid for neurosurgical infections: efficacy, safety and cost study.Linezolid interaction with serotonin reuptake inhibitors: report of two cases and incidence assessment.Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients.Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter survey.
P2860

Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.

Item
http://www.wikidata.org/entity/Q33368368
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.
@ast
Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.
@en
type
label
Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.
@ast
Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.
@en
prefLabel
Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.
@ast
Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.
@en
P1433
P1476
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P356
P1433
P1476
Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.
@en
P2888
P304
P31
P356
10.2165/00019053-200523090-00006
P433
P478
P50
P577
P6179
P698
P921